Princeton Global Asset Management LLC Purchases 200 Shares of Corteva, Inc. $CTVA

Princeton Global Asset Management LLC grew its position in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 61.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 525 shares of the company’s stock after purchasing an additional 200 shares during the period. Princeton Global Asset Management LLC’s holdings in Corteva were worth $39,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CTVA. Gladwyn Financial Advisors Inc. bought a new stake in Corteva during the second quarter worth about $25,000. Maryland Capital Advisors Inc. bought a new stake in Corteva during the second quarter worth about $29,000. Valley National Advisers Inc. lifted its stake in Corteva by 85.9% during the first quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock worth $33,000 after purchasing an additional 243 shares during the last quarter. Richardson Capital Management LLC bought a new stake in Corteva during the first quarter worth about $37,000. Finally, DHJJ Financial Advisors Ltd. lifted its stake in Corteva by 132.2% during the second quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock worth $39,000 after purchasing an additional 300 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Insider Buying and Selling at Corteva

In other Corteva news, EVP Robert D. King sold 37,280 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the transaction, the executive vice president owned 49,262 shares in the company, valued at approximately $3,655,240.40. This represents a 43.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.15% of the company’s stock.

Corteva Stock Down 0.1%

Shares of NYSE:CTVA opened at $61.93 on Wednesday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The company has a market cap of $42.05 billion, a PE ratio of 30.21, a P/E/G ratio of 1.42 and a beta of 0.76. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23. The stock’s 50-day moving average is $69.04 and its 200 day moving average is $68.97.

Corteva (NYSE:CTVAGet Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The company had revenue of $6.46 billion for the quarter, compared to the consensus estimate of $6.26 billion. During the same quarter in the previous year, the business earned $1.83 EPS. Corteva’s revenue was up 5.6% compared to the same quarter last year. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd were issued a dividend of $0.18 per share. This is a positive change from Corteva’s previous quarterly dividend of $0.17. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.2%. Corteva’s dividend payout ratio (DPR) is currently 35.12%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CTVA. Argus dropped their price target on Corteva from $83.00 to $80.00 and set a “buy” rating for the company in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $83.00 to $90.00 and gave the company a “buy” rating in a research note on Monday, September 15th. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 1st. Weiss Ratings lowered Corteva from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, October 8th. Finally, UBS Group lowered their target price on Corteva from $91.00 to $85.00 and set a “buy” rating for the company in a research note on Monday, October 6th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.31.

Get Our Latest Stock Analysis on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Featured Articles

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.